Prediction of the renal replacement therapy requirement in mechanically ventilated critically ill patients by combining biomarkers for glomerular filtration and tubular damage

Journal of Critical Care

Volumn 29, Issue 4, 2014, Pages 692.e7-692.e13

  Pipili, Chrysoula ^a   Ioannidou, Sophia ^b   Tripodaki, Elli Sophia ^a   Parisi, Maria ^a   Douka, Evangelia ^a   Vasileiadis, Ioannis ^a   Joannidis, Michael ^c   Nanas, Serafim ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Combination of biomarkers; Prediction; Renal replacement therapy; Urinary neutrophil gelatinase associated lipocalin

Indexed keywords

CREATININE; CYSTATIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; CYSTATIN C BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN URINE LEVEL; OBSERVATIONAL STUDY; PREDICTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; RENAL SYSTEM PARAMETERS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; ACUTE KIDNEY INJURY; AGED; AREA UNDER THE CURVE; BLOOD; CRITICAL ILLNESS; GLOMERULUS FILTRATION RATE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; APACHE; AREA UNDER CURVE; BIOLOGICAL MARKERS; CRITICAL ILLNESS; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84902261664     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.02.011     Document Type: Article

References (46)

1. Joannidis M., Metnitz P.G. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 2005, 21(2):239-249.
2. Clec'h C., Darmon M., Lautrette A., Chemouni F., Azoulay E., Schwebel C., et al. Efficacy of renal replacement therapy in critically ill patients: a propensity analysis. Crit Care 2012, 16:R236-R245.
3. Metnitz P.G., Krenn C.G., Steltzer H., Lang T., Ploder J., Lenz K., et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002, 30:2051-2058.
4. Karvellas C.J., Farhat M.R., Sajjad I., Mogensen S.S., Leung A.A., Wald R., et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011, 15:R72-R90.
5. Seabra V.F., Balk E.M., Liangos O., Sosa M.A., Cendoroglo M., Jaber B.L., et al. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 2008, 52:272-284.
6. Joannidis M., Forni L.G. C linical review: timing of renal replacement therapy. Crit Care 2011, 15:223-247.
7. Joannidis M., Forni L.G. Renal replacement therapy: to treat, or not to treat, that is the question. Crit Care 2013, 17:125-129.
8. Bouman C.S., Oudemans-Van Straaten H.M., Tijssen J.G., Zandstra D.F., Kesecioglu J., et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002, 30:2205-2211.
9. Payen D., Mateo J., Cavaillon J.M., Fraisse F., Floriot C., Vicaut E., et al. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 2009, 37:803-810.
10. Allegretti A.S., Steele D.J., David-Kasdan J.A., Bajwa E., Niles J.L., Bhan I., et al. Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study. Crit Care 2013, 20:R109-R119.
11. Kox M., Pickkers P. "Less is more" in critically ill patients: not too intensive. JAMA Intern Med 2013, 173:1369-1372.
12. McDermid R.C., Stelfox H.T., Bagshaw S.M. Frailty in the critically ill: a novel concept. Crit Care 2011, 15:301-328.
13. Ronco C., McCullough P.A., Anker S.D., Anand I., Aspromonte N., Bagshaw S.M., et al. Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2010, 165:54-67.
14. Cruz D.N., de Cal M., Garzotto F., Perazella M.A., Lentini P., Corradi V., et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 2010, 36:444-451.
15. Lehner G.F., Pechlaner C., Graziadei I.W., Joannidis M. Monitoring of organ functions. Dysfunction of kidneys, liver, gastrointestinal tract, and coagulation. Med Klin Intensivmed Notfmed 2012, 107:7-16.
16. Mishra J., Dent C., Tarabishi R., Mitsnefes M.M., Ma Q., Kelly C., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
17. Zhang Z., Lu B., Sheng X., Jin N. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis 2011, 58:356-365.
18. Bellomo R., Ronco C. Indications and criteria for initiating renal replacement therapy in the intensive care unit. Kidney Int Suppl 1998, 66:S106-S109.
19. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
20. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
21. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
22. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009, 136:e28-e39.
23. Grenier F.C., Ali S., Syed H., Workman R., Martens F., Liao M., et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem 2010, 43:615-620.
24. Heagerty P.J., Lumley T., Pepe M.S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56:337-344.
25. Liangos O., Perianayagam M.C., Vaidya V.S., Han W.K., Wald R., Tighiouart H., et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:904-912.
26. Vanmassenhove J., Vanholder R., Nagler E., Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 2013, 28:254-273.
27. de Geus H.R., Bakker J., Lesaffre E.M., le Noble J.L. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 2011, 183:907-914.
28. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024.
29. Siew E.D., Ware L.B., Gebretsadik T., Shintani A., Moons K.G., Wickersham N., et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 2009, 20:1823-1832.
30. Kokkoris S., Parisi M., Ioannidou S., Douka E., Pipili C., Kyprianou T., et al. Neutrophil gelatinase-associated lipocalin and cystatin C for early detection of acute kidney injury in ICU adults. Ren Fail 2012, 34:1100-1108.
31. Endre Z.H., Pickering J.W., Walker R.J., Devarajan P., Edelstein C.L., Bonventre J.V., et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011, 79:1119-1130.
32. Ralib A.M., Pickering J.W., Shaw G.M., Devarajan P., Edelstein C.L., Bonventre J.V., et al. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 2012, 23:322-333.
33. Singer E., Elger A., Elitok S., Kettritz R., Nickolas T.L., Barasch J., et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int 2011, 80:405-414.
34. Waikar S.S., Sabbisetti V.S., Bonventre J.V. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010, 78:486-494.
35. Herget-Rosenthal S., Marggraf G., Husing J., Göring F., Pietruck, Janssen O., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66:1115-1122.
36. Nejat M., Pickering J.W., Walker R.J., Endre Z.H. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 2010, 25:3283-3289.
37. Royakkers A.A., Korevaar J.C., van Suijlen J.D., Hofstra L.S., Kuiper M.A., Spronk P.E., et al. Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy. Intensive Care Med 2011, 37:493-501.
38. Rogers J., Fuller H.D. Use of daily Acute Physiology and Chronic Health Evaluation (APACHE) II scores to predict individual patient survival rate. Crit Care Med 1994, 22:1402-1405.
39. Cruz D.N., de Geus H.R., Bagshaw S.M. Biomarker strategies to predict need for renal replacement therapy in acute kidney injury. Semin Dial 2011, 24:124-131.
40. Endre Z.H., Pickering J.W. New markers of acute kidney injury: giant leaps and baby steps. Clin Biochem Rev 2011, 32:121-124.
41. Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010, 15:419-428.
42. Haase M., Devarajan P., Haase-Fielitz A., Bellomo R., Cruz D.N., Wagener G., et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011, 57:1752-1761.
43. Kokkoris S., Pipili C., Grapsa E., Kyprianou T., Nanas S. Novel biomarkers of acute kidney injury in the general adult ICU: a review. Ren Fail 2013, 35:579-591.
44. Giasson J., Li G.H., Chen Y. Neutrophil gelatinase-associated lipocalin (NGAL) as a new biomarker for non-acute kidney injury (AKI) diseases. Inflamm Allergy Drug Targets 2011, 10:272-282.
45. Liu X., Hamnvik O.P., Petrou M., Gong H., Chamberland J.P., Christophi C.A., et al. Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study. Eur J Endocrinol 2011, 165:805-812.
46. Bagshaw S.M., Bellomo R. Cystatin C in acute kidney injury. Curr Opin Crit Care 2010, 16:533-539.